Sebela Pharmaceuticals
UEI: GYJGX9EN3P94
• CAGE: 724C9
Overview
Parent Awardee
Federal Capability Statement
Sebela Pharmaceuticals owns the Anal-pram and Pramosonc lines of products. These are RX products. Analpram Advanced Kit is for hemorrhoids. PramosoneE and Pramosone Lotion are low potency steroids for treating atopic dermatitis.
Keywords
Pharma sales, pharma products, pharmaceuticals, rx products, rx medications, medications, not supplies, pharmaceutical, anal pram, anal-pram kit, pramosone, pramosome lotion, hemorrhoids, anal discomfort, atopic dermatitis, gastroenterology, dermatology
Website
Headquarters
Roswell, GA
United States
United States
Federal recipient
SEBELA PHARMACEUTICALS INC.
(UEI GYJGX9EN3P94, CAGE 724C9)
is headquartered in Roswell GA.
Its primary registered NAICS is 325412 Pharmaceutical Preparation Manufacturing.
The corporation
was founded in August 2013 and
federally registered in
January 2014.
Federal Registration and Certifications
Legal Name
SEBELA PHARMACEUTICALS INC.
UEI
GYJGX9EN3P94
CAGE Code
724C9
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Aug. 26, 2013
Initial Registration
Jan. 27, 2014
Last Registration
April 29, 2025
Registration Activation
April 29, 2025
Registration Expiration
April 28, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Manufacturer of Goods
Manufacturer of Goods
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Disaster Registry
Specific Regions
Reported NAICS
Accepts Credit Cards
No
People
Vendor contacts at Sebela Pharmaceuticals
GSA Schedules and Price Lists
- Sebela Pharmaceuticals
- PoP: 3/31/24 - 3/31/29
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Sebela Pharmaceuticals
- PoP: 8/14/16 - 3/31/24 (Ended)
- Type: Pharmaceuticals and Drugs (FSS 65 I B)